Peak6 Investments LLC Fulgent Genetics, Inc. Transaction History

Peak6 Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$21.55 - $29.29 $382,189 - $519,458	-17,735 Reduced 99.42%	103 $2,000
Q4 2023 Feb 13, 2024	BUY	$23.64 - $30.27 $412,990 - $528,816	17,470 Added 4747.28%	17,838 $515,000
Q3 2023 Nov 13, 2023	SELL	$26.74 - $40.81 $374,279 - $571,217	-13,997 Reduced 97.44%	368 $9,000
Q2 2023 Aug 11, 2023	SELL	$28.52 - $40.7 $106,379 - $151,811	-3,730 Reduced 20.61%	14,365 $531,000
Q1 2023 May 12, 2023	SELL	$29.39 - $36.27 $706,447 - $871,821	-24,037 Reduced 57.05%	18,095 $564,000
Q4 2022 Feb 10, 2023	BUY	$29.23 - $40.28 $629,643 - $867,671	21,541 Added 104.61%	42,132 $1.26 Million
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $780,810 - $1.31 Million	20,591 New	20,591 $785,000
Q1 2022 May 13, 2022	BUY	$49.85 - $96.11 $231,553 - $446,430	4,645 Added 1055.68%	5,085 $317,000
Q3 2021 Nov 12, 2021	BUY	$74.87 - $110.87 $32,942 - $48,782	440 New	440 $40,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.